Replies to post #445762 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

At this point it seems so obvious that DCVAX will continue on with compassionate use while Advent and "Sawston" focus their attention on contracts and backlog in a variety of different biologic manufacturing services.

I'd bet that's a soon come PR about a confirmatory / P4 "Real world" trial. It's possible the EU will divide GBM SOC between the chemo protocol and a new DC vaccine protocol (various DC's including DCBAX).

Common shareholders had better keep their eye on the prize by watching closely the "Sawston" / Advent arrangement, and NWBO authorized / debt. It could easily all just slip away.